We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+5.87%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$161M
Cap. Flow
-$719M
Cap. Flow %
-3.91%
Top 10 Hldgs %
44.79%
Holding
252
New
8
Increased
23
Reduced
112
Closed
6

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$52.7M
2
AAPL icon
Apple
AAPL
+$48M
3
GILD icon
Gilead Sciences
GILD
+$46.1M
4
PM icon
Philip Morris
PM
+$45.8M
5
KO icon
Coca-Cola
KO
+$37.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 32.02%
2 Energy 16.75%
3 Financials 15.83%
4 Technology 10.16%
5 Healthcare 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAG icon
201
Conagra Brands
CAG
$7.42B
$394K ﹤0.01%
9,766
PB icon
202
Prosperity Bancshares
PB
$8.9B
$385K ﹤0.01%
5,519
MSGS icon
203
Madison Square Garden
MSGS
$9.59B
$375K ﹤0.01%
2,630
ALXN
204
DELISTED
Alexion Pharmaceuticals
ALXN
$373K ﹤0.01%
3,075
-9,875
-76% -$1.27M
WRI
205
DELISTED
Weingarten Realty Investors
WRI
$367K ﹤0.01%
10,979
AMCX icon
206
AMC Global Media
AMCX
$450M
$365K ﹤0.01%
6,220
GSK icon
207
GSK
GSK
$107B
$352K ﹤0.01%
6,682
-328
-5% -$16.6K
MLM icon
208
Martin Marietta Materials
MLM
$34.2B
$352K ﹤0.01%
1,612
PYPL icon
209
PayPal
PYPL
$50.3B
$346K ﹤0.01%
8,053
-550
-6% -$23K
SHW icon
210
Sherwin-Williams
SHW
$84.8B
$339K ﹤0.01%
3,276
DHR icon
211
Danaher
DHR
$138B
$338K ﹤0.01%
4,463
GS icon
212
Goldman Sachs
GS
$289B
$334K ﹤0.01%
1,452
REGN icon
213
Regeneron Pharmaceuticals
REGN
$72.9B
$334K ﹤0.01%
+863
New +$320K
ETP
214
DELISTED
Energy Transfer Partners L.p.
ETP
$332K ﹤0.01%
9,101
QQQ icon
215
Invesco QQQ Trust
QQQ
$436B
$324K ﹤0.01%
2,444
SYK icon
216
Stryker
SYK
$135B
$314K ﹤0.01%
2,385
UL icon
217
Unilever
UL
$142B
$307K ﹤0.01%
5,528
CVS icon
218
CVS Health
CVS
$135B
$306K ﹤0.01%
3,893
-312
-7% -$24.9K
ENB icon
219
Enbridge
ENB
$120B
$306K ﹤0.01%
+7,302
New +$308K
OMC icon
220
Omnicom Group
OMC
$23.5B
$304K ﹤0.01%
3,530
-223
-6% -$19K
AMP icon
221
Ameriprise Financial
AMP
$47.8B
$291K ﹤0.01%
2,240
-100
-4% -$12.4K
EBAY icon
222
eBay
EBAY
$51.2B
$289K ﹤0.01%
8,603
BIVV
223
DELISTED
Bioverativ Inc. Common Stock
BIVV
$264K ﹤0.01%
+4,856
New +$239K
EXP icon
224
Eagle Materials
EXP
$6.49B
$255K ﹤0.01%
2,625
SRCL
225
DELISTED
Stericycle Inc
SRCL
$249K ﹤0.01%
3,000

Similar funds

Fayez Sarofim & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.88% from $18.2B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Fayez Sarofim & Co withdrew a net $719M in Q1 2017, closing 6 positions and reducing 112 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $2.53M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, up from 31% a quarter earlier, followed by Energy and Financials.

Against the trend, Fayez Sarofim & Co opened a new position in Service Corp International worth $2.3M.

  • Fayez Sarofim & Co's largest Q1 2017 buy was Service Corp International: 74,500 shares worth $2.3M.
  • Fayez Sarofim & Co added most to Microsoft in Q1 2017, an estimated $33.7M increase.
  • Fayez Sarofim & Co's biggest Q1 2017 reduction was AB InBev, cutting an estimated $52.7M.
  • Fayez Sarofim & Co fully exited State Street SPDR S&P 500 ETF Trust in Q1 2017, selling an estimated $2.53M.
  • Fayez Sarofim & Co's ten largest holdings make up 45% of its $18.4B portfolio in Q1 2017.
  • Fayez Sarofim & Co opened 8 new positions and closed 6 in Q1 2017.
  • Fayez Sarofim & Co's portfolio value rose 0.88% quarter-over-quarter to $18.4B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2017, filed 12 May 2017.